- Home
- APLM vs FLYE Comparison
APLM vs FLYE Comparison
Compare APLM & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- FLYE
- Stock Information
- Founded
- APLM 2016
- FLYE 2018
- Country
- APLM United States
- FLYE United States
- Employees
- APLM N/A
- FLYE N/A
- Industry
- APLM Blank Checks
- FLYE Aerospace
- Sector
- APLM Finance
- FLYE Industrials
- Exchange
- APLM Nasdaq
- FLYE Nasdaq
- Market Cap
- APLM 15.6M
- FLYE 15.4M
- IPO Year
- APLM N/A
- FLYE 2024
- Fundamental
- Price
- APLM $0.10
- FLYE $0.58
- Analyst Decision
- APLM Strong Buy
- FLYE
- Analyst Count
- APLM 2
- FLYE 0
- Target Price
- APLM $4.25
- FLYE N/A
- AVG Volume (30 Days)
- APLM 1.2M
- FLYE 376.9K
- Earning Date
- APLM 08-14-2024
- FLYE 11-26-2024
- Dividend Yield
- APLM N/A
- FLYE N/A
- EPS Growth
- APLM N/A
- FLYE 1.84
- EPS
- APLM N/A
- FLYE 0.06
- Revenue
- APLM $2,101,000.00
- FLYE $32,236,745.00
- Revenue This Year
- APLM N/A
- FLYE N/A
- Revenue Next Year
- APLM N/A
- FLYE N/A
- P/E Ratio
- APLM N/A
- FLYE $10.39
- Revenue Growth
- APLM 70.54
- FLYE 36.51
- 52 Week Low
- APLM $0.10
- FLYE $0.51
- 52 Week High
- APLM $1.79
- FLYE $7.62
- Technical
- Relative Strength Index (RSI)
- APLM 34.54
- FLYE N/A
- Support Level
- APLM $0.11
- FLYE N/A
- Resistance Level
- APLM $0.13
- FLYE N/A
- Average True Range (ATR)
- APLM 0.01
- FLYE 0.00
- MACD
- APLM -0.00
- FLYE 0.00
- Stochastic Oscillator
- APLM 4.02
- FLYE 0.00
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About FLYE Fly-E Group Inc. Common Stock
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.